Sorrento Therapeutics Inc (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRNE | AMGN | VRTX | GILD | BMY |
| Company | Sorrento Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.0031 | 319.59 | 503.00 | 96.35 | 59.82 |
| High | 0.0050 | 321.22 | 508.04 | 96.84 | 60.62 |
| Low | 0.0031 | 293.80 | 489.02 | 94.23 | 58.81 |
| Last | 0.0050 | 298.84 | 490.00 | 94.35 | 59.02 |
| Change | +0.0010 | -22.97 | -11.72 | -2.68 | -0.80 |
| % Change | +25.00% | -7.14% | -2.34% | -2.76% | -1.34% |
| Volume | 195,656 | 6,487,423 | 1,158,060 | 8,288,937 | 14,121,575 |
| 20-Day Average Volume | 223,843 | 2,024,200 | 1,113,332 | 6,147,653 | 10,236,188 |
| Previous Close | 0.0040 | 321.81 | 501.72 | 97.03 | 59.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0034 | 318.12 | 484.41 | 90.08 | 54.24 |
| 20-Day Raw Stochastic | 46.81% | 14.39% | 48.20% | 67.89% | 77.83% |
| 20-Day Relative Strength | 52.14% | 33.98% | 53.39% | 67.78% | 66.40% |
| Weighted Alpha | -87.41 | +6.57 | +34.20 | +36.17 | +26.64 |
| Today's Opinion | 72% Sell | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 56% Buy | 48% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +25.00% since 11/05/24 | -6.43% since 11/05/24 | -1.88% since 11/05/24 | +4.89% since 11/05/24 | +5.50% since 11/05/24 |
| Low | 0.0006 on 11/08/24 | 293.80 on 11/12/24 | 485.29 on 11/06/24 | 90.50 on 11/06/24 | 53.97 on 11/08/24 |
| High | 0.0100 on 11/08/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 1-Month | |||||
| %Chg | +42.86% since 10/11/24 | -9.01% since 10/11/24 | +1.82% since 10/11/24 | +11.39% since 10/11/24 | +13.07% since 10/11/24 |
| Low | 0.0006 on 11/08/24 | 293.80 on 11/12/24 | 463.14 on 11/01/24 | 84.34 on 10/14/24 | 51.31 on 10/15/24 |
| High | 0.0100 on 11/08/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 3-Month | |||||
| %Chg | -23.08% since 08/12/24 | -6.64% since 08/12/24 | +5.59% since 08/12/24 | +29.65% since 08/12/24 | +25.42% since 08/12/24 |
| Low | 0.0005 on 09/04/24 | 293.80 on 11/12/24 | 447.70 on 10/07/24 | 72.67 on 08/13/24 | 46.88 on 08/22/24 |
| High | 0.0200 on 08/22/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -62.96% since 05/10/24 | -3.67% since 05/10/24 | +16.02% since 05/10/24 | +43.47% since 05/10/24 | +31.34% since 05/10/24 |
| Low | 0.0002 on 05/17/24 | 293.80 on 11/12/24 | 422.44 on 05/14/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 0.0210 on 07/17/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,205 | 172,983,504 | 129,207,448 | 120,801,568 | 121,325,552 |
| Shares Outstanding, K | 551,281 | 537,533 | 257,529 | 1,244,992 | 2,028,177 |
| Annual Sales | 62,840,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -572,840,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 15,030,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -95,210,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.84 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 10/04/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.92 | 0.00 | 21.80 | 46.27 |